Abstract
Objective
To determine prognostic factors in patients with systemic rheumatic diseases admitted to the intensive care unit (ICU) and to examine whether the observed mortality rate is predicted using the Acute Physiology And Chronic Health Assessment II (APACHE II) score.
Design and setting
Retrospective study with historical controls in a 31-bed medicosurgical ICU at a university hospital.
Patients and participants
Seventy-one patients admitted to the ICU for an acute illness related to a systemic rheumatic disease and/or its treatment and 353 ICU control patients.
Results
Systemic rheumatic diseases were mainly rheumatoid arthritis and vasculitides. In-hospital mortality rate was 28/71 (39%), including 23 patients who died in the ICU. Multivariable logistic regression showed that poor prior health status (Berdit’s classification), APACHE II score, and admission for infection were associated with mortality, whereas prior use of immunosuppressive agents was not. APACHE II score at admission was higher in nonsurvivors (22±9) than in survivors (17±5) (p<0.01). The standard mortality ratio, i.e., the ratio between observed and predicted mortality, was 1.7 in the 71 study patients and 1.0 in the 353 control patients (p<0.0001).
Conclusions
In patients with systemic rheumatic diseases admitted to the ICU for at least 48 h, poor prior chronic health status, APACHE II score, and infection were prognostic factors for in-hospital mortality. SMR was higher than in a control ICU population.
References
Janssen NM, Karnad DR, Guntupalli KK (2002) Rheumatologic diseases in the intensive care unit: epidemiology, clinical approach, management and outcome. Crit Care Clin 18:729–748
Thong BY, Tai DY, Goh SK, Johan A (2001) An audit of patients with rheumatic disease requiring medical intensive care. Ann Acad Med Singapore 30:254–259
Pourrat O, Bureau JM, Hira M, Martin-Barbaz F, Descamps JM, Robert M (2000) Outcome of patients with systemic rheumatic disease admitted to intensive care units: a retrospective study of 39 cases. Rev Med Interne 21:147–151
Godeau B, Mortier E, Roy PM, Chevret S, Bouachour G, Schlemmer B, Carlet J, Dhainaut JF, Chastang C (1997) Short and long-term outcomes for patients with systemic rheumatic diseases admitted to intensive care units: a prognostic study of 181 patients. J Rheumatol 24:1317–1323
Bouachour G, Roy PM, Tirot P, Guerin O, Gouello JP, Alquier P (1996) Prognosis of systemic diseases diagnosed in intensive care units. Presse Med 25:837–841
Ansell SM, Bedhesi S, Ruff B, Mahomed AG, Richards G, Mer M, Feldman C (1996) Study of critically ill patients with systemic lupus erythematosus. Crit Care Med 24:981–984
Godeau B, Boudjadja A, Dhainaut JF, Schlemmer B, Chastang C, Brunet F, Le Gall JR (1992) Outcome of patients with systemic rheumatic disease admitted to medical intensive care units. Ann Rheum Dis 51:627–631
Kollef MH, Enzenauer RJ (1992) Predicting outcome from intensive care for patients with rheumatologic diseases. J Rheumatol 19:1260–1262
Berdit M, Williamson JE (1973) Function limitation scale for measuring health outcome in health status indexes. Hospital Research and Educational Trust, Chicago
Knauss WA, Draper EA, Wagner DP, Zimmerman JE (1985) APACHE II: a severity of disease classification system. Crit Care Med 13:818–829
Peres Bota D, Mélot C, Ferreira FL, Vincent JL (2003) Infection probability score: a simple method to help assess the probability of infection in critically ill patients. Crit Care Med 31:2579–2584
Bland M (1996) An introduction to medical statistics, 2nd edn. Oxford University Press, Oxford
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Moreels, M., Mélot, C. & Leeman, M. Prognosis of patients with systemic rheumatic diseases admitted to the intensive care unit. Intensive Care Med 31, 591–593 (2005). https://doi.org/10.1007/s00134-005-2563-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00134-005-2563-y